Physician profile
Peter I Ellman
NPI 1053529214
$4,079.36
in general payments reported to CMS, 2019-2025
35 companies · $49.64 in 2025
The $49.64 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,114 · 2020: $161 · 2021: $436 · 2022: $490 · 2023: $1,436 · 2024: $393 · 2025: $49.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,136 · Food and Beverage: $743.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,135.57 |
| Food and Beverage | $743.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,218.33 | 2019-2023 | Da Vinci Surgical System |
| Edwards Lifesciences Corporation | $449.08 | 2019-2023 | Konect Resilia |
| Atricure, INC. | $299.51 | 2019-2022 | |
| Abiomed | $193.49 | 2020-2024 | Impella |
| Seagen INC. | $177.38 | 2021-2023 | Padcev, Tukysa |
| Medtronic, INC. | $170.65 | 2021-2024 | Illumisite |
| Healthmyne, INC. | $154.05 | 2019 | |
| Irhythm Technologies, INC. | $122.16 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Servier Pharmaceuticals LLC | $95.65 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $95.04 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $84.67 | 2019 | |
| Medtronic Vascular, INC. | $84.33 | 2019 | |
| Abbott Laboratories | $83.81 | 2021 | |
| Auris Health, INC. | $79.93 | 2019 | |
| Merck Sharp & Dohme LLC | $72.54 | 2022-2023 | Verquvo, Lynparza, Keytruda |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $70.00 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $65.61 | 2019-2022 | |
| Astrazeneca Pharmaceuticals Lp | $59.63 | 2019-2020 | |
| Scpharmaceuticals INC. | $58.50 | 2023 | |
| Amgen INC. | $52.63 | 2022-2023 | Lumakras |
| Eisai INC. | $40.77 | 2022-2024 | |
| La Jolla Pharmaceutical Company | $38.17 | 2024 | Giapreza |
| Jazz Pharmaceuticals INC. | $36.86 | 2022-2023 | |
| Genentech USA, INC. | $34.51 | 2019-2023 | Gavreto, Tecentriq, Alecensa |
| E.R. Squibb & Sons, L.L.C. | $30.44 | 2023 | Camzyos |
| Cvrx, INC. | $29.37 | 2025 | Barostim Neo System |
| Boston Scientific Corporation | $29.26 | 2021 | |
| Lilly USA, LLC | $24.92 | 2019-2021 | |
| Lexicon Pharmaceuticals, INC. | $24.35 | 2024 | |
| Beigene USA, INC. | $22.68 | 2023 | Brukinsa |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $18.45 | 2022 | |
| Janssen Pharmaceuticals, INC | $17.56 | 2022 | |
| Pfizer INC. | $17.19 | 2024 | |
| Impulse Dynamics (USA) INC. | $15.31 | 2023 | Optimizer |
| Exelixis INC. | $12.53 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Ellman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.